Next Article in Journal
Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
Next Article in Special Issue
S Trimer Derived from SARS-CoV-2 B.1.351 and B.1.618 Induced Effective Immune Response against Multiple SARS-CoV-2 Variants
Previous Article in Journal
A Quantum Vaccinomics Approach for the Design and Production of MSP4 Chimeric Antigen for the Control of Anaplasma phagocytophilum Infections
Previous Article in Special Issue
Nucleic Acid Vaccines against SARS-CoV-2
 
 
Article

Article Versions Notes

Vaccines 2022, 10(12), 1996; https://doi.org/10.3390/vaccines10121996
Action Date Notes Link
article xml file uploaded 24 November 2022 09:24 CET Original file -
article xml uploaded. 24 November 2022 09:24 CET Update https://www.mdpi.com/2076-393X/10/12/1996/xml
article pdf uploaded. 24 November 2022 09:24 CET Version of Record https://www.mdpi.com/2076-393X/10/12/1996/pdf
article supplementary file uploaded. 24 November 2022 09:24 CET - https://www.mdpi.com/2076-393X/10/12/1996#supplementary
article html file updated 24 November 2022 09:25 CET Original file -
article html file updated 3 March 2023 22:31 CET Update https://www.mdpi.com/2076-393X/10/12/1996/html
Back to TopTop